Material Type

• Blood (whole) (5)
• Buffy coat (1)
• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Isolated peripheral blood mononuclear cells (viable) (2)
• Other (2)
• Pathogen DNA (Derivative) (1)
• Plasma (double spun) (2)
• Plasma (single spun) (3)
• Red Blood Cells (1)
• Saliva (2)
• Serum (5)
• Stool (1)
• Swab medium (2)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Not applicable (5)

Storage Temperature

• RT (1)
• -85°C to -60°C (5)
• Liquid nitrogen (2)

Preservation Type

• N/A (3)

Associated Data

• Biomarker datasets (1)
• Clinical records (4)
• Followup records (4)
• Freezer temperature logs (3)
• Microbiological results (2)
• Physiological/biochemical measurements (3)
• Pre-analytical data (3)
• Quality indicators (3)
• Survey data (3)
• Treatment records (2)

Timeframe

• Immediate (1)
• 0 - 3 months (5)
• 3 - 6 months (2)
• > 6 months (1)

Participant Count

• 11 - 100 (1)
• 101 - 500 (4)
• 501 - 1000 (1)

Sex

• Both sexes (5)

Age Range

• Young child (2 - 6 years) (1)
• Young adult (18 - 40 years) (2)
• Adult (> 40 years) (3)

Biobank Services

• Ability to recontact (3)
• Cell culture (2)
• Data analytics (2)
• Digital imaging (1)
• Immunohistochemistry - staining (1)
• Nucleic acid extraction (2)

Collection Type

• Case-control (1)
• Cohort (2)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (4)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (5)
• No restrictions (0)
• No Project specific restriction (4)
• No Scope of use restriction (2)

Collection Status

• Completed (1)
• In progress (5)

Access Condition

• Open to applicants (3)
• Open only through collaboration (2)
• Data access only (1)

Country

• Germany (1)
• Peru (1)
• South Africa (1)
• Spain (1)
• Uganda (1)

County